Harriet de Wit
Direktor/Vorstandsmitglied bei PHARMALA BIOTECH HOLDINGS INC.
Vermögen: 15 800 $ am 30.04.2024
Profil
Harriet de Wit is currently a Director at Pharmala Biotech Holdings, Inc. and Pharmala Biotech, Inc. She is also a Professor at The University of Chicago.
She received her doctorate degree from Concordia University in 1981 and her undergraduate degree from the University of Calgary.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
27.02.2024 | 100 000 ( 0,12% ) | 15 800 $ | 30.04.2024 |
Aktive Positionen von Harriet de Wit
Unternehmen | Position | Beginn |
---|---|---|
PHARMALA BIOTECH HOLDINGS INC. | Direktor/Vorstandsmitglied | 21.03.2021 |
The University of Chicago | Corporate Officer/Principal | - |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ausbildung von Harriet de Wit
University of Calgary | Undergraduate Degree |
Concordia University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
PharmAla Biotech Holdings, Inc. | |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |